Navigation Links
To fight incurable metastatic breast cancer, resistance must be broken
Date:12/10/2012

One of the most frustrating truths about cancer is that even when a treatment works, it often doesnt work for long because cancer cells find ways to resist. However, researchers reporting studies done in mice in the December 11, 2012, issue of Cancer Cell, a Cell Press publication, may have a way to stay one step ahead in the case of aggressive metastatic breast cancer.

The findings emphasize the importance of basic cancer biology for advancing treatments that are more effective and less toxic, the researchers say.

"We need to gain a better understanding of the wiring diagram of cancer cells in order to anticipate resistance mechanisms and plan the right combination therapies," says Mohamed Bentires-Alj of the Friedrich Miescher Institute for Biomedical Research in Switzerland. "Moreover, we need to better understand how cancer progresses to metastases."

After all, the spreading of cancer through metastasis is responsible for most cancer-related deaths.

In the new study, Bentires-Alj and his colleagues examined cancer cell lines and primary breast tumors to see what happens when those cancers are treated with a new type of therapy that targets the so-called PI3K pathway.

"The PI3K pathway is frequently mutated and activated in several human cancers where it plays a key role in tumor development and maintenance as well as in resistance to therapy," Bentires-Alj says, which explains why clinical trials evaluating some 26 PI3K inhibitors are now underway.

While those inhibitors are promising, there is some bad news, as the new work shows. When triple-negative breast tumors are hit with PI3K inhibitors, cancer cells begin to produce a chemical that ramps up a second cancer pathway (JAK2/STAT5)one that encourages the cancer to spread.

Now for the good news: when the researchers treated mice with an aggressive form of breast cancer with drugs to block both PI3K and JAK2/STAT5 pathways, their tumors grew more slowly, spread less readily, and, ultimately, the animals lived longer.

If Bentires-Alj has his way, the findings in mice will lead to clinical trials in the patients who are most likely to benefit: those with particularly aggressive, triple-negative breast cancers.

"We are in the era of personalized medicine," he says. "We hope that this combination therapy will be tested in clinical trials and that the right patients will be selected for these studies."


'/>"/>

Contact: Mary Beth O'Leary
moleary@cell.com
617-397-2802
Cell Press
Source:Eurekalert

Related medicine news :

1. DXE Medical, Inc. Donates to Franklin Firefighters Annual Christmas Toy and Clothing Drive
2. Teen Fighting Declines in U.S., Europe
3. Cocktail boosts immune cells in fighting cancer
4. Use Social Media to Fight Childhood Obesity, Heart Experts Say
5. St. Louis Rams Seek Flawless Execution® Training from Fighter Pilots to Take Back Season
6. 5 big strides to fight lung disease in our tiniest patients
7. Colorful Fruits, Vegetables May Be Key to Cancer-Fighting Diet
8. University of Tennessee study: Unexpected microbes fighting harmful greenhouse gas
9. Virtual reality could help people lose weight, fight prejudice
10. New bacteria to fight against intestinal inflammation
11. Could Cholesterol Treatment Fight Repeat Heart Attack?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2017)... ... May 24, 2017 , ... In modern ... the most appropriate instruments for research and understanding the basic principles that were ... will focus on innovations in stereo microscopy for brightfield and fluorescence typically used ...
(Date:5/24/2017)... ... ... Altec Products, Inc., a leader in enterprise document management and ... in San Diego, CA. , At nVerge 2017, Altec will be highlighting ... their Sage ERP solutions by providing improved visibility and control to the entire document ...
(Date:5/24/2017)... , ... May 24, 2017 , ... ... implants in Bayside, NY, who have now spent 10 years as clinical instructors ... York University (NYU) College of Dentistry. Through the program, private practitioners receive cutting-edge ...
(Date:5/24/2017)... ... 2017 , ... Patients who want to receive cosmetic dentistry procedures such as ... Bedich for a consultation, with or without a referral. Dr. Bedich enjoys improving the ... , Dr. Bedich offers a variety of cosmetic dentistry services at his practice ...
(Date:5/24/2017)... ... 2017 , ... Myers Jackson is well known for auctioning homes that people ... anywhere on the planet. The luxury home market is alive and well and there ... quick search of “11 Spyglass Hill Auction will enlighten you on the dynamics of ...
Breaking Medicine News(10 mins):
(Date:5/11/2017)... , May 11, 2017  Thornhill Research ... has been awarded an $8,049,024 USD five-year, firm-fixed-priced, ... through the Canadian Commercial Corporation (CCC) ( ... Anesthesia Systems to administer general anesthesia to patients ... "The US Marine Corps have been ...
(Date:5/10/2017)... BARRINGTON, Ill. , May 10, 2017 ... medicine today; unfortunately its costs have also spiraled to ... are being sent to radiology than ever before as ... and diagnosis.  For a patient with lower back pain ... prove no anatomical reason for pain, resulting in entirely ...
(Date:5/9/2017)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ... on the development of oral drug delivery systems, ... has granted Oramed a patent titled, "Methods and ... covers Oramed,s invention of an oral glucagon-like peptide-1 ... hormone that stimulates the secretion of insulin from ...
Breaking Medicine Technology: